Tenet Healthcare (NYSE:THC) Earns Overweight Rating from Analysts at Morgan Stanley

Morgan Stanley assumed coverage on shares of Tenet Healthcare (NYSE:THCFree Report) in a report issued on Wednesday, MarketBeat Ratings reports. The brokerage issued an overweight rating and a $165.00 price target on the stock.

THC has been the topic of several other reports. TD Cowen initiated coverage on Tenet Healthcare in a research note on Wednesday, February 26th. They issued a “buy” rating and a $175.00 target price on the stock. Barclays cut their target price on shares of Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating for the company in a research report on Thursday, February 13th. Cantor Fitzgerald reissued an “overweight” rating and issued a $177.00 price target on shares of Tenet Healthcare in a research report on Thursday, February 13th. JPMorgan Chase & Co. reiterated an “overweight” rating and issued a $175.00 price objective on shares of Tenet Healthcare in a research note on Tuesday, December 17th. Finally, The Goldman Sachs Group downgraded Tenet Healthcare from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $196.00 to $140.00 in a research report on Monday, December 16th. Three analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Tenet Healthcare currently has an average rating of “Moderate Buy” and an average target price of $166.41.

Get Our Latest Report on THC

Tenet Healthcare Trading Down 0.9 %

Shares of Tenet Healthcare stock opened at $133.17 on Wednesday. The stock has a fifty day moving average price of $132.43 and a 200-day moving average price of $142.50. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.78 and a quick ratio of 1.70. The firm has a market cap of $12.67 billion, a PE ratio of 4.13, a P/E/G ratio of 1.02 and a beta of 2.06. Tenet Healthcare has a 1 year low of $90.03 and a 1 year high of $171.20.

Tenet Healthcare (NYSE:THCGet Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, topping the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. Equities research analysts anticipate that Tenet Healthcare will post 12.24 EPS for the current year.

Insider Transactions at Tenet Healthcare

In related news, Director J Robert Kerrey sold 9,525 shares of the company’s stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the sale, the director now directly owns 27,378 shares in the company, valued at $3,434,022.54. This represents a 25.81 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.93% of the company’s stock.

Institutional Trading of Tenet Healthcare

Large investors have recently modified their holdings of the business. True Wealth Design LLC bought a new stake in shares of Tenet Healthcare in the 3rd quarter worth approximately $38,000. Colonial Trust Co SC increased its position in Tenet Healthcare by 85.7% during the 4th quarter. Colonial Trust Co SC now owns 247 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the period. GeoWealth Management LLC lifted its position in shares of Tenet Healthcare by 39.8% in the 4th quarter. GeoWealth Management LLC now owns 295 shares of the company’s stock worth $37,000 after purchasing an additional 84 shares during the period. WR Wealth Planners LLC boosted its stake in shares of Tenet Healthcare by 2,836.4% during the 4th quarter. WR Wealth Planners LLC now owns 323 shares of the company’s stock valued at $41,000 after purchasing an additional 312 shares in the last quarter. Finally, Smartleaf Asset Management LLC increased its position in shares of Tenet Healthcare by 30.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 471 shares of the company’s stock valued at $59,000 after buying an additional 110 shares during the period. 95.44% of the stock is owned by institutional investors.

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Further Reading

Analyst Recommendations for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.